Cancer of oesophagus or gastricus: New assessment of technology of endosonography (COGNATE): Report of pragmatic randomised trial

Health Technology Assessment

Volumn 17, Issue 39, 2013, Pages 1-13

  Russell, I ^a   Edwards, R ^a   Gliddon, A ^a   Ingledew, D ^a   Russell, D ^a   Whitaker, R ^a   Yeo, S ^a   Attwood, S ^a   Barr, H ^a   Nanthakumaran, S ^a   Park, K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL DECISION MAKING; MULTICENTER STUDY; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; ENDOSONOGRAPHY; ENGLAND; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE; QUESTIONNAIRES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84884476018     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta17390     Document Type: Article

References (36)

1. Blot W. Esophageal cancer trends and risk factors. Sem Oncol. 1994; 21, 403-410.
2. Hansson L., Sparen P., Nyren O. Increasing incidence of both major histological types of esophageal carcinomas amongst men in Sweden. Int J Cancer. 1993; 54, 402-407.
3. Devesa S., Blot W., Fraumeni J. Changing patterns in the incidence of esophageal an gastric carcinoma in the United States. Cancer 1998; 83, 2049-2053.
4. McKinney P., Sharp L., McFarlane G. Oesophagel and Gastric cancer in Scotland 1960-1990. Br J Cancer. 1995; 71, 411-415.
5. Office for National Statistics, Registration of cancer diagnosed in 1993-1996, England and Wales. Health Statistics Quarterly. 1999; 4, 59-70.
6. Allum WH., Powell DJ., McConkey CC., Fielding JWL. Gastric cancer a 25 year review. Br J Surg. 1989; 76, 535-540
7. Muller JM., Erasmit T., Stelsner M., Zieren U., Pichmaier H. Sugical therapy of oesophageal cancer. Br J Surg. 1990; 77, 845-857.
8. MacIntyre IMC., Akoh JA. Improving survival in gastric cancer. Review of operative mortality in English language publications from 1970. Br J Surg. 1991; 78, 773-778.
9. Cushieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347,995-999.
10. Bonnenkamp JJ., Songun J., Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345, 745-748.
11. Anderson, DN., Campbell, S., Park, KGM. The accuracy of laparoscopic ultrasound in the staging of upper gastrointestinal malignancy. Br J Surg. 1996; 83, 1424-1428.
12. Oliver SE., Robertson CS., Logan RFA. Oesophageal cancer: a population based study of survival after treatment. Br J Surg. 1992; 79,1321-1325.
13. Nakamura K., Ueyama T., Yao T et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastretomy. Cancer 1992; 70, 1030.
14. Pye JK, Crumplin MKH, Charles J, Kerwat R, Foster ME, Biffin A. One-year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg. 2001; 88, 278-285.
15. De Boer AGEM., Onorbe Genovesi PI., Sprangers MAG., van Sandick JW., Obertop H., van Lanschot JJB. Quality of life in long-term survivors after curative transhiatal oesophageactomy for oesophageal carcinoma. Br J Surg. 2000; 87, 1716-1721.
16. Cooper JS., Guo MD., Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281, 1623-1627.
17. Walsh TN., Noonan N., Hollywood D., et al A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Eng J Med. 1996; 335, 462-467.
18. Urba S., Orringer MD., Turriss A et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19, 305-313.
19. Bossett JF., Gigoux M., Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161-167.
20. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48, 151-152.
21. Fujita H., Sueyoshi S., Yamana H., et al. Optimal treatment strategy for superficial esophageal cancer, mucosal resection versus radical esophagectomy. World J Surg. 2001; 25, 424-431.
22. Tajima Y., Nakanishi Y., Ochiai A., et al Histopathological findings predicting lymph node metastasis in patients with superficial esophageal carcinoma: analysis of resected tumours. Cancer 2000; 88, 1285-1293.
23. Samuelsson L., Hambraeus GM., Mercke CE., Tylen U. CT staging of oesophageal carcinoma. Acta Radiologica. 1984; 25, 7-11.
24. Sondenaa K., Skaane P., Nygaard K., Skjennald A. Value of computed tomography in preoperative evaluation of respectability and staging in oesophageal carcinoma. Eu J Surg. 1992; 158, 537-540.
25. Van Overhagen H., Lmeris JS., Berger MY., et al. CT assessment of respectability prior to transhiatal oesophagectomy for oesophageal/gastroesophageal junctional carcinoma. J Compt Assist Tomogr. 1993; 17, 367-373.
26. Trenker SW., Halvorsen RA., Thompson WM. Neoplasms of the upper gastrointestinal tract. Radiol Clin N Am. 1994; 32, 15-24.
27. Botet JF., Lightdale CJ., Zauber AG, et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 1991; 181, 419-425.
28. Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5, 537-547.
29. Vickers J., Alderson D. Oesophageal cancer staging using endoscopic ultrasonography. Br J Surg. 1998; 85, 994-998.
30. Richards DG., Brown TH., Manson JM. Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. Ann R Coll Surg Engl. 2000; 82, 311-317.
31. Harris KM, Kelly S, Berry E et al. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. Health Technology Assessment 1998; 2.
32. Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50 (Suppl V): V1-V23.
33. Kelly S, Harris KM, Berry E, Hutton J, Roderick P, Cullingworth J et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49: 534-539.
34. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of Clinical Oncology 1993; 11: 570-579.
35. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, 3rd ed. Oxford: Oxford University Press; 2003.
36. Scottish Audit of Gastro-Oesophageal Cancer. www.show.scot.nhs.uk/crag. Edinburgh: Scottish Executive Health Department; 2002.